Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684775 · ClinicalTrials.gov registry record · Phase 2
Employment-Based Depot Naltrexone Clinical Trial II
A Phase 2 study of Opiate Dependence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT00684775 is a Phase 2 study of Opiate Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 38 participants, below the 605-participant average among 15 other Opiate Dependence trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00684775, a Phase 2 study of Opiate Dependence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether employment-based naltrexone treatment proves effective in promoting depot naltrexone adherence and drug abstinence.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Work Plus Naltrexone Contingency
Study Locations (1)
Maryland
- The Center for Learning and Health - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00684775
The ClinicalTrials.gov registry entry for NCT00684775 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 605-participant average among 15 other Opiate Dependence trials with a reported enrollment target (94% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opiate Dependence appearing as the primary indexed condition, and to 1 intervention - of which Work Plus Naltrexone Contingency is the first listed.
NCT00684775 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00684775 about?
NCT00684775 is a clinical study titled "Employment-Based Depot Naltrexone Clinical Trial II". The purpose of this study is to determine whether employment-based naltrexone treatment proves effective in promoting depot naltrexone adherence and drug abstinence.
What is the current status of trial NCT00684775?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2008-05. Estimated completion is 2010-04-30.
What conditions does trial NCT00684775 study?
This clinical trial studies the following conditions: Opiate Dependence.
What interventions are being tested in trial NCT00684775?
The interventions under investigation include: Work Plus Naltrexone Contingency (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT00684775?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00684775 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants
COMPLETED · Phase 2
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
-
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.